Determination of the minimum effective concentration (MEC90) of dexmedetomidine for prolonged analgesia in patients undergoing interscalene brachial plexus block
Not Applicable
Active, not recruiting
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Registration Number
- KCT0002933
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Adult (>20 years old or =20, <70 years old)
patients with written informed consent
American society of anesthesiologist physical status I-III: Previous healthy (I), controlled systemic disease (II), uncontrolled systemic disease (III)
Exclusion Criteria
American society of anesthesiologist physical status higher than IV
Child or old age
Sensory or motor deficit
Allergy to local anesthetic
Allergy to dexmedetomidine
Local infection at the site of interscalene brachial plexus block or systemic infection
Hepatic, cardiac, or renal disease
Coagulopathy (Prolonged INR>1.5)
Pregnancy
Patient refusal
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to first pain at surgical site
- Secondary Outcome Measures
Name Time Method The incidence of hypotension;The incidence of bradycardia;cumulative opioid consumption at 24 hours postoperatively;patient satisfaction with pain relief;Quality of sleep at the fisrt postoperative night;pain score;block-related complications